Supriya Chopra, MD, on Cervical Cancer: Reducing Late Effects of Bowel Toxicity

March 22, 2021 By The ASCO Post Staff

Supriya Chopra, MD, of Tata Memorial Centre, discusses a final analysis of the phase III PARCER trial, which showed that image-guided intensity-modulated radiotherapy is superior to conventional radiotherapy in reducing bowel toxicity in women with cervical cancer. Acute diarrhea was also reduced, with no difference in disease-related outcomes (ID# 10224).

Related Content